Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06325332
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-03-15
Brief Title:
BEYFORTUS Nirsevimab Effectiveness Against Medically-Attended RSV Events in Infants BEAR Study
Sponsor:
Sanofi Pasteur a Sanofi Company
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Respiratory Syncytial Virus |
Keywords:
| Name | View |
|---|---|
| RSV | View |